Emrelis - Side Effects, Interactions, Uses, Dosage, Warnings | Everyday Health

Emrelis (Intravenous)

Emrelis (Intravenous)

Telisotuzumab vedotin is used in adults to treat non-squamous non-small cell lung cancer that has spread to other parts of the body (metastatic), or after other treatments did not work or stopped working.

Your doctor will make sure you have the correct tumor type to be treated with telisotuzumab vedotin.

Telisotuzumab vedotin may also be used for purposes not listed in this medication guide.

uses

What is Emrelis (Intravenous) used for?

  • Non-Small Cell Lung Cancer

warnings

What is the most important information I should know about Emrelis (Intravenous)?

Tell your doctor if you have or have ever had:

  • nerve problems;
  • other lung or breathing problems besides lung cancer;
  • eye problems; or
  • liver disease.

Telisotuzumab vedotin can harm an unborn baby if the mother or the father is using this medicine.

  • If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 2 months after your last dose.
  • If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.
  • Tell your doctor right away if a pregnancy occurs.

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

Telisotuzumab vedotin may affect fertility in men or women. Pregnancy could be harder to achieve while either parent is using this medicine.

User Reviews & Rating

No ratings yet for Emrelis (Intravenous)

Leave a Review

Side Effects

What are the side effects of Emrelis (Intravenous)?

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Telisotuzumab vedotin can cause severe and life-threatening side effects. Call your doctor right away if you have numbness, tingling, muscle weakness, or burning pain in your hands or feet, blurred vision, eye pain, swelling, or redness, increased sensitivity to light, fever, cough, wheezing, or feeling short of breath.

Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

  • loss of appetite;
  • abnormal blood tests;
  • nerve problems, swelling in the feet, ankles, legs or hands; or
  • tired feeling.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Pregnancy & Breastfeeding

Can I take Emrelis (Intravenous) if I’m pregnant or breastfeeding?

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

Interactions

What drugs and food should I avoid while taking Emrelis (Intravenous)?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Dosage Guidelines & Tips

How to take Emrelis (Intravenous)?

Use Emrelis (Intravenous) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Your doctor will perform tests to make sure telisotuzumab vedotin is the right treatment for you.

Telisotuzumab vedotin is injected into a vein by a healthcare provider once every 2 weeks. Your doctor will determine the right treatment schedule for you.

You may need frequent medical tests including vision exams, and your cancer treatments may be changed or delayed based on the results.

You will be watched for a short time to make sure you do not have an allergic reaction.

You may be given other medications to help prevent serious side effects or an allergic reaction. Keep using these medicines for as long as your doctor has prescribed.

Doses are based on weight. Your dose may change if you gain or lose weight.

Call your doctor for instructions if you miss an appointment for your telisotuzumab vedotin injection.

Overdose Signs

What happens if I overdose on Emrelis (Intravenous)?

In a medical setting an overdose would be treated quickly.

If you think you or someone else may have overdosed on: Emrelis (Intravenous),  call your doctor or the Poison Control center
(800) 222-1222
If someone collapses or isn't breathing after taking Emrelis (Intravenous), call 911
911

Medical Disclaimer

Drugs A-Z provides drug information from Everyday Health and our partners, as well as ratings from our members, all in one place. Cerner Multum™ provides the data within some of the Overview, Uses, Warnings, Side Effects, Pregnancy, Interactions, Dosage, Overdose, and Images sections. The information within all other sections is proprietary to Everyday Health.